Originally regarded as a simple barrier against passive leakage of fluid into lung airspaces critical for gas exchange, the alveolar epithelium is now viewed as a key regulator of alveolar homeostasis. Furthermore, alterations in alveolar epithelium are central to the pathogenesis of a number of diseases impacting respiratory health including idiopathic pulmonary fibrosis (IPF) and emphysema, making it important to understand mechanisms responsible for its normal maintenance and repair following injury. My research program is thematically focused on alveolar epithelial cell (AEC) plasticity/?reprogramming?, with the overall goal of characterizing the molecular basis of AEC function and phenotype in order to elucidate mechanisms leading to aberrant repair and develop strategies for improving outcome following injury, consistent with the mission of NHLBI. Our work to date has contributed to new paradigms in AEC biology, including demonstration of an active role for alveolar epithelial type I (AT1) cells in alveolar homeostasis, AEC plasticity, a central role for alveolar epithelium in pulmonary fibrosis, discovery of a novel role of tight junctions (TJ) in regulation of lung stem/progenitor cell homeostasis, and elucidation of key pathways regulating AEC differentiation. Building on this work, we will focus going forward on complementary areas of 1) regulation of normal AEC phenotype/differentiation, 2) role of AEC in lung fibrosis and 3) regulation of endogenous lung stem/progenitor cell homeostasis coordinated by interactions with TJ, in order to address key gaps in our understanding of normal AEC progenitor potential/differentiation and disruption in disease. Success will be ensured by a) synergistic interactions among a strong team with expertise in AEC differentiation, lung development, epigenetics/bioinformatics and regenerative medicine and b) use of innovative models (e.g., induced pluripotent cells (iPSC) from normal and IPF patients) to investigate AEC differentiation in health and disease. Application of genome-wide genomic and high-throughput technologies will provide potentially transformative insights into previously unexplored cell-specific epigenetic (especially histone) modifications regulating normal and aberrant differentiation of normal and IPF AEC. Novel insights regarding regulation of lung stem/progenitor function by intracellular transduction of signals from TJ have the potential to be harnessed to augment lung regeneration after injury. Deliverables with broad application to the lung research community include improved methods for AT1 cell isolation, novel AT1 cell markers/Cre lines, and genome-wide datasets to be deposited as a shared resource. Our integrated team approach using primary (including human) AEC, spheroid cultures and iPSC, together with genome-wide transcriptomic/epigenomic analyses and disease modelling, to address critical questions related to AEC maintenance and repair has significant translational potential. Although aspects of the program are potentially high-risk, these are precisely the types of studies that provide new innovative research opportunities and will benefit most from the long-term support provided by this award.

Public Health Relevance

Abnormalities of the cells of the alveolar epithelium that line the gas exchange surface of the lung contribute to the development of a number of chronic lung diseases, including idiopathic pulmonary fibrosis (IPF) and emphysema. My research program aims to understand biology of the alveolar epithelium in the context of lung injury, repair and fibrosis. A comprehensive understanding of cellular and molecular pathways that regulate maintenance of the normal alveolar epithelium and are disrupted in disease will provide the framework for developing strategies for therapeutic approaches to chronic lung diseases.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Unknown (R35)
Project #
5R35HL135747-04
Application #
9962973
Study Section
Special Emphasis Panel (ZHL1)
Program Officer
Lin, Sara
Project Start
2017-07-01
Project End
2024-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
4
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Southern California
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
072933393
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Zhou, Beiyun; Flodby, Per; Luo, Jiao et al. (2018) Claudin-18-mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesis. J Clin Invest 128:970-984
Luo, Jiao; Chimge, Nyam-Osor; Zhou, Beiyun et al. (2018) CLDN18.1 attenuates malignancy and related signaling pathways of lung adenocarcinoma in vivo and in vitro. Int J Cancer 143:3169-3180
Lax, Siân; Rayes, Julie; Wichaiyo, Surasak et al. (2017) Platelet CLEC-2 protects against lung injury via effects of its ligand podoplanin on inflammatory alveolar macrophages in the mouse. Am J Physiol Lung Cell Mol Physiol 313:L1016-L1029
Stueve, Theresa Ryan; Li, Wen-Qing; Shi, Jianxin et al. (2017) Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers. Hum Mol Genet 26:3014-3027